Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
Alberto BorghettiArturo CicculloFrancesca LombardiDiana GiannarelliRosa Anna PasserottoFrancesco LamannaAntonella CarcagnìDamiano FarinacciAlex DusinaGianmaria BaldinMaurizio ZazziSimona Di GiambenedettoPublished in: Open forum infectious diseases (2024)
DT was not associated with a significantly higher risk of VF than dolutegravir-based TT.